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Detection of the Abnormal Isoform
of the Prion Protein Associated
With Chronic Wasting Disease in
the Optic Pathways of the Brain
and Retina of Rocky Mountain
Elk (Cervus elaphus nelsoni)
T. R. Spraker1, K. I. O’Rourke2, T. Gidlewski3, J. G. Powers4,
J. J. Greenlee5, and M. A. Wild4
Abstract
Eyes and nuclei of the visual pathways in the brain were examined in 30 Rocky Mountain elk (Cervus elaphus nelsoni) representing
3 genotypes of the prion protein gene PRNP (codon 132: MM, ML, or LL). Tissues were examined for the presence of the abnormal
isoform of the prion protein associated with chronic wasting disease (PrPCWD). Nuclei and axonal tracts from a single section
of brain stem at the level of the dorsal motor nucleus of the vagus nerve were scored for intensity and distribution of
PrPCWD immunoreactivity and degree of spongiform degeneration. This obex scoring ranged from 0 (elk with no PrPCWD in
the brain stem) to 10 (representing elk in terminal stage of disease). PrPCWD was detected in the retina of 16 of 18 (89%) elk
with an obex score of > 7. PrPCWD was not detected in the retina of the 3 chronic wasting disease–negative elk and 9 elk
with an obex score of < 6. PrPCWD was found in the nuclei of the visual pathways in the brain before it was found in the
retina. Within the retina, PrPCWD was first found in the inner plexiform layer, followed by the outer plexiform layer.
Intracytoplasmic accumulation of PrPCWD was found in a few neurons in the ganglion cell layer in the PRNP 132ML elk but
was a prominent feature in the PRNP 132LL elk. Small aggregates of PrPCWD were present on the inner surface of the outer
limiting membrane in PRNP 132LL elk but not in PRNP 132MM or 132ML elk. This study demonstrates PrPCWD accumulation
in nuclei of the visual pathways of the brain, followed by PrPCWD in the retina.
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Chronic wasting disease (CWD), a transmissible spongiform
encephalopathy, has been reported in captive and free-
ranging cervids.3,32,37,38 An abnormal isoform of the prion pro-
tein has been found in cervids with CWD (PrPCWD), and it can
be detected with immunohistochemistry.33 PrPCWD has been
reported in the brain, lymphoid tissues, and other organs
(including the retina) in mule deer and white-tailed deer with
CWD.9,16,27,32 Misfolded prion proteins have been associated
with other transmissible spongiform encephalopathies and
have been reported in retinas of domestic sheep inoculated with
the scrapie agent7,14 and in humans with sporadic and variant
Creutzfeldt–Jakob disease.10 This communication documents
the occurrence of PrPCWD in the retina, optic nerve, and visual
pathways of the brain in Rocky Mountain elk with natural
occurring CWD. Disease progression in preclinical elk with
natural exposure to CWD was estimated from the intensity and
distribution of immunoreactivity and spongiform change in the
brain stem at the level of the dorsal motor nucleus of the vagus
nerve (obex score). Distribution of PrPCWD in the retina and
optic pathways was a late-stage event, observed only in elk
with relatively high obex scores. Minor variation in the
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distribution pattern of PrPCWD in the retina may be associated
with a polymorphism at codon 132 of the PRNP gene, a site
associated with incubation time in elk8,23 and relative
susceptibility and disease expression in humans (human codon
129) with sporadic and acquired transmissible spongiform
encephalopathies.19
Materials and Methods
Eyes and brain were collected postmortem from 27 Rocky
Mountain elk diagnosed with CWD by immunohistochemistry
assay of antemortem biopsy samples of rectal mucosal-
associated lymphoid tissue31,34 or postmortem assay of brain
and lymphoid tissues.33 Negative-control elk included 2
ranch-raised elk from a herd free of a history of CWD and 1
free-ranging elk with no detectable PrPCWD in brain or lym-
phoid tissues.
The open reading frame of the PRNP gene was sequenced in
all the elk as described.22 The previously described coding
change at codon 132 was detected; elk were identified as homo-
zygous for the wild-type allele encoding methionine (132MM),
homozygous for the alternative allele encoding leucine
(132LL), or heterozygous for the alleles (132ML).
Fourteen elk (47%) were free-ranging adult cows (eleven
132MM, three 132ML) originating from north-central Color-
ado and 11 elk (37%) originating from captive herds in north-
ern Colorado. The captive group included 8 bulls (seven
132MM, one 132ML) and 3 cows (two 132MM, one
132ML). In addition, two 132LL elk experimentally fed a
pooled brain homogenate from two 132ML CWD-positive elk
were examined.8,23 Both were euthanized at 60 months
postinfection.
Following euthanasia, eyes were collected within 1 to
5 minutes from each elk. The globe of each eye was opened via
an incision through the sclera just posterior to the limbus, thus
increasing exposure of the retina to fixative. Eyes were placed
in Davidson’s fixative for 3 days.13 Brains were collected
within 4 hours of death from each elk, hemisectioned, placed
in 10% neutral buffered formalin, and fixed for 1 week. The
formalin was changed at least twice for each brain. Sections
from each brain were cut at 5 mm and immunolabeled as
previously described with anti–prion protein monoclonal anti-
body F99/97.6.133 (mAb99; Anti-Prion (99), Ventana Medical
Systems, Inc, Tucson, AZ) and monoclonal antibody P4
(mAbP4).36 The latter binds an epitope at residues 93–99, near
the amino terminus of the processed prion protein; the former
binds an epitope at residues 220–225, near the carboxyl
terminus of the processed prion protein.21 Hematoxylin and
eosin–stained sections were examined from all sections for
spongiform degeneration.29
To confirm the CWD status, one section of obex was exam-
ined from each elk (ie, brain stem at the level where the fourth
ventricle converges into the central canal of the spinal cord);
this section contained the dorsal motor nucleus of the vagus
nerve (DMNV), medial retropharyngeal lymph node, and pala-
tine tonsil. In addition, the stage of the disease was estimated
by scoring the degree of detectable positive chromogen immu-
noreactivity in the nuclei and white matter tracts, combined
with the degree of spongiform degeneration in this section. The
evaluated nuclei included the DMNV, area postrema, solitary
nucleus, cuneate nucleus, nucleus of the spinal tract of the tri-
geminal nerve, nucleus ambiguus, reticular formation area/
nucleus, olivary nuclei, medial raphe, and hypoglossal
nucleus.39 The obex was scored as a progressive increase in
intensity of PrPCWD immunoreactivity and distribution, essen-
tially as described,30 with additional classification criteria
based on the intensity of spongiform degeneration and PrPCWD
in axonal tracts. An obex score of 0 was assigned to elk with no
detectable PrPCWD in the brain stem. Scoring of samples with
detectable PrPCWD in the obex ranged from 1, characterized
by minimal immunoreactivity of the ventral aspects of the
DMNV (Fig. 1), to 10, characterized by all the nuclei and axo-
nal tracts containing a moderate to heavy PrPCWD immunoreac-
tivity (Fig. 2). All nuclei had mild to severe spongiform
degeneration. Intermediate stages were defined by an increase
in immunoreactivity intensity and spongiform degeneration.
A detailed description of this scoring system is in preparation.
Eyes from each animal and brain sections of the proposed
visual pathways were trimmed and embedded in paraffin
blocks. The visual pathways within the brain of elk have not
been described; therefore, the visual pathways described in
humans were applied. The pathway is assumed to include, in
order, retina, optic nerve, optic chiasm, optic tract, lateral gen-
iculate nucleus, optic radiations, and visual cortex of the occi-
pital lobe—all of which were sampled. Impulses leaving the
lateral geniculate nucleus also travel to the superior colliculus
(sampled) and midbrain tectum; these are primarily reflex. The
oculomotor nucleus (sampled), even though not directly a part
of the visual pathway, was examined because this nucleus con-
trols multiple functions of the eye, including pupillary
size.1,2,26 Immunoreactivity intensity was scored as 0 (no label-
ing detected), 0.5 (trace amounts of chromogen in some areas
of the region), 1 (light labeling within the region), 2 (moderate
labeling in the region), and 3 (heavy chromogen deposits
throughout the region). Elk were grouped by obex score, and
the median value was calculated for each group at each ana-
tomic site in the visual pathway.
Results
Clinical Status and PRNP Genotype of
the Test Population
Of the 27 CWD-positive elk, 20 were nonclinical and 7 showed
typical clinical signs of CWD at the time of euthanasia. Clinical
signs included behavior changes, mild to moderate aggression
when cornered, weight loss, excessive salivation, grinding of
the teeth, and emaciation. PRNP genotypes in the 25 naturally
infected elk included twenty 132MM elk (80%) and five
132ML elk (20%), a ratio similar to that observed in the natural
population.22,24 Elk homozygous for the 132L allele are rela-
tively rare in the population; therefore, 2 experimentally
Spraker et al 537
Figure 1. Subgross photograph of a cross section of the brain stem at the level of the obex of an elk with an obex score of 2. Note the scant
red granular staining in the ventral aspects of the dorsal motor nucleus of the vagus nerve (circled). Inset: Circled area. Note the minimal
degree of red granular PrPCWD staining on the periphery of neurons and within the neuropil of the dorsal motor nucleus of the vagus nerve.
Immunohistochemical staining: Anti Prion (99) monoclonal antibody 99, streptavidin–alkaline–phosphatase method. Hematoxylin/bluing
counterstain. PrPCWD, prion protein associated with chronic wasting disease. Figure 2. Subgross photograph of a cross section of the obex of
an elk with an obex score of 10. Note the extensive red granular staining in all the nuclear areas, with less staining in axonal tracts. Inset: Circled
area within the vagus nucleus. Note the extensive red granular PrPCWD staining within the neuropil and on the periphery of neurons throughout
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infected animals described in previous studies8,23 were added
to this study.
Obex Scores of Preclinical and Clinically Affected Elk
The obex was scored in all 30 elk based on the distribution and
intensity of immunoreactivity combined with the degree of
spongiform degeneration. Neither PrPCWD detected by immu-
noreactivity nor spongiform degeneration was observed in the
brain stem from the 3 negative control elk. Of the twenty
132MM CWD-positive elk, obex scores were as follows: one
1, two 2s, one 3, one 4, one 6, three 7s, three 8s, three 9s, and
five 10s (Table 1). Of the five 132ML-positive elk, the obex
scores were as follows, one of each: 4, 5, 6, 8, 10. One
132LL elk had an obex score of 8 and the other, a score of 9.
Elk with obex scores of < 9 were clinically normal except for
2 elk, 1 with a score of 8 and the other, a score of 9; both these
elk had pneumonia at the time of necropsy.
PrPCWD in the Brain and Visual Pathway of Elk at
Different Stages of CWD
Immunoreactivity of the visual pathway was scored at 9
neuroanatomic locations in samples from elk with obex scores
ranging from 1 to 10. Table 2 shows the median scores for each
location in relation to the obex score. The earliest sites of
PrPCWD immunoreactivity were the visual cortex (1 of 2) and
superior colliculus (2 of 2) in the brain of elk with an obex
score of 2. Heaviest PrPCWD immunoreactivity was observed
in the superior colliculus, oculomotor nucleus, visual cortex,
lateral geniculate nucleus, and retina in elk with an obex score
of 9 or 10. At each location, visual pathway scores were higher
in elk with higher obex scores. PrPCWD immunoreactivity was
detected in the retina of elk with obex scores of 7 or higher. The
character and location of the PrPCWD immunoreactivity varied
with obex score and genotype, as follows.
Obex score ¼ 0. Neither histological lesions nor PrPCWD
immunoreactivity was detected in obex, brain, lymphoid tis-
sues, or sections of the visual pathway including the eye of the
3 control elk.
Obex score ¼ 1. One 132MM elk had an obex score of 1.
This elk had no detectable PrPCWD immunoreactivity in the
visual pathways of the brain or retina. Spongiform
degeneration was not found in any of the nuclei of the visual
pathway. Histological lesions were not detected in any of the
layers of the retina.
Obex score ¼ 2. Two 132MM elk had an obex score of 2.
PrPCWD immunoreactivity was detected in the visual cortex
of 1 elk and in the superior colliculus in both elk. The pattern
of PrPCWD immunoreactivity was considered to be trace and
primarily linear. Evidence of spongiform degeneration was not
found in any of the nuclei of the visual pathway. Histological
lesions or PrPCWD immunoreactivity was not detected in any
of the layers of the retina.
Obex score ¼ 3. One 132MM elk had an obex score of 3.
PrPCWD immunoreactivity was detected in the visual cortex
in this elk (Fig. 3A). The pattern of PrPCWD immunoreactivity
was considered to be mild and primarily linear. No evidence of
spongiform degeneration was found in any of the nuclei of the
visual pathway. Histological lesions or PrPCWD immunoreac-
tivity was not detected in any of the layers of the retina in this
elk.
Obex score ¼ 4. Two elk (one 132MM and one 132ML) had
an obex score of 4. PrPCWD immunoreactivity was detected in
the lateral geniculate nucleus, the oculomotor nucleus, superior
colliculus, and visual cortex in the 132MM elk but only in the
visual cortex in the 132ML elk. The pattern of PrPCWD immu-
noreactivity was primarily linear, but coarse granules of chro-
mogen were found in the visual cortex and lateral geniculate
nucleus in the 132MM elk and in the superior colliculus in both
elk. Spongiform degeneration was confined to the DMNV in
both elk and not found in nuclei of the visual pathway. Histo-
logical lesions or PrPCWD immunoreactivity was not detected
in any of the layers of the retina in these 2 elk.
Obex score ¼ 5. One elk (132ML) had an obex score of 5.
PrPCWD immunoreactivity was detected in the lateral genicu-
late nucleus, superior colliculus, visual cortex, and oculomotor
nucleus in this elk. Both linear and granular patterns were
found in this stage, but the linear pattern was more prominent.
Spongiform degeneration was confined to the obex and not
found in nuclei of the visual pathway. Histological lesions or
PrPCWD immunoreactivity was not detected in any of the layers
of the retina in this elk.
Figure 2. (continued) the dorsal motor nucleus of the vagus nerve. Immunohistochemical staining: Anti Prion (99) monoclonal antibody 99,
streptavidin–alkaline–phosphatase method. Hematoxylin/bluing counterstain. PrPCWD, prion protein associated with chronic wasting disease.
Figure 3. Photomicrograph of the visual cortex from two 132MM CWD-positive elk. A, an elk with an obex score of 3. B, an elk with an obex
score of 10. Note the linear staining (arrow) of PrPCWD (A) compared to the course granular staining (arrow) with plaque formation (B).
Immunohistochemical staining: Anti Prion (99) monoclonal antibody 99, streptavidin–alkaline–phosphatase method. Hematoxylin/bluing
counterstain. 132MM: codon 132, elk identified as homozygous for the wild-type allele encoding methionine. CWD, chronic wasting disease;
PrPCWD, prion protein associated with chronic wasting disease. Figure 4. Photomicrograph of the superior colliculus from two 132MM positive
CWD elk. A, an elk with an obex score of 6. Note the minimal amount of linear (L) and granular (G) staining of PrPCWD. B, an elk with an obex
score of 10. Note the lack of linear staining with the abundance of granular staining and plaque formation (arrow). Immunohistochemical staining:
Anti Prion (99) monoclonal antibody 99, streptavidin–alkaline–phosphatase method. Hematoxylin/bluing counterstain. 32MM: codon 132, elk
identified as homozygous for the wild-type allele encoding methionine. CWD, chronic wasting disease; PrPCWD, prion protein associated with
chronic wasting disease.
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Obex score ¼ 6. Two elk (one 132MM and one 132ML) had
an obex score of 6. PrPCWD immunoreactivity was detected in
the superior colliculus (Fig. 4A), visual cortex, and oculomotor
nucleus in the 132ML elk. PrPCWD immunoreactivity was
detected in the lateral geniculate nucleus, superior colliculus,
visual cortex, and oculomotor nucleus in the 132MM elk. Both
Table 2.Median PrPCWD Immunoreactivity Intensity Scores of Rocky Mountain Elk With Disease Progression as Estimated From Obex Scores
(Number of Elk Affected)
Obex
Score
No.
Elk Retina
Optic
Nerve
Optic
Chiasm
Optic
Tract
Lateral Geniculate
Nucleus
Optic
Radiations
Visual
Cortex
Oculomotor
Nucleus
Superior
Colliculus
1 1 0 0 0 0 0 0 0 0 0
2 2 0 0 0 0 0 0 0.5 (1) 0 0.8 (2)
3 1 0 0 0 0 0 0 1.0 (1) 0 0
4 2 0 0 0 0 0.5 (1) 0 1.0 (2) 0.5 (1) 0.5 (1)
5 1 0 0 0 0 1.0 (1) 0 1.0 (1) 2.0 (1) 1.0 (1)
6 2 0 0 0 0 0.5 (1) 0 2.0 (2) 1.3 (2) 2.0 (2)
7 3 0.7 (2) 0 0 0.2 (1) 0.7 (2) 0.7 (2) 1.0 (3) 1.7 (3) 1.7 (3)
8 5 1.4 (4) 0.9 (4) 0.7 (4) 0.7 (4) 1.9 (5) 1.6 (5) 2.0 (5) 2.0 (5) 2.2 (5)
9 4 2.8 (4) 1.3 (3) 0.6 (3) 0.9 (4) 2.0 (4) 1.8 (4) 1.5 (4) 2.3 (4) 2.3 (4)
10 6 2.5 (6) 1.5 (6) 2.7 (3)a 1.7 (6) 3.0 (6) 2.0 (6) 3.0 (6) 3.0 (6) 3.0 (6)
PrPCWD, prion protein associated with chronic wasting disease. Immunoreactivity in the retina was not observed until an obex score of > 7 was obtained.
Immunoreactivity intensity was scored as 0 (no labeling detected), 0.5 (trace amounts of chromogen in some areas of the region), 1 (light labeling within the
region), 2 (moderate labeling in the region), and 3 (heavy chromogen deposits throughout the region). The number in parentheses is the number of elk in each
category affected.
a The optic chiasm was collected in only 3 of these 6 elk.
Table 1. Rocky Mountain Elk in Which Eyes Were Collected For Examination
Elk No. PRNP Genotypea Sourceb Clinical Signs Obex Scorec PrPCWD in Retinad
T78-6110 MM F No 1 N
T78-6121 MM F No 2 N
T78-6111 MM F No 2 N
T78-6473 MM R No 3 N
T78-6054 ML F No 4 N
T78-6071 MM F No 4 N
T78-6130 ML F No 5 N
T78-6113 ML F No 6 N
T78-6136 MM F No 6 N
T78-6070 MM F No 7 N
T78-6073 MM F No 7 P
T78-6098 MM F No 7 P
T78-6055 MM F No 8 N
T67-6540 MM R No 8 P
T67-4413 LL E No 8 P
T89-0104 ML R Yes 8 P
T67-6790 MM R No 8 P
T78-6487 MM R No 9 P
T67-4412 LL E Yes 9 P
T78-1987 MM F No 9 P
T67-6541 MM R No 9 P
T78-6474 MM R Yes 10 P
T56-7353 MM R Yes 10 P
T56-1821 MM R No 10 P
T45-7445 ML R Yes 10 P
T78-0368 MM F Yes 10 P
T89-3530 MM R Yes 10 P
n, 27.
a Deduced amino acid at residue 132 of the PRNP gene. M, methionine; L, leucine.
b R, ranch-raised elk; F, free-ranging elk; E, experimental oral exposure.
c Obex score based on absence (0) or relative intensity of immunolabeling and spongiform degeneration (1–10) in a single section of medulla at the level of the
dorsal motor nucleus of the vagus.
d PrPCWD, prion protein associated with chronic wasting disease. Immunolabeling of the retina: P, elk with; N, elk without.
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Figure 5. Photomicrograph of the retina in 2 CWD-positive 132MM elk. A, an elk with an obex score of 7. Note the minimal bright red
granular chromogen deposition in the inner plexiform (IP) layer and the absence of staining in the outer plexiform (OP) and outer limiting
membrane (OLM) layers. B, an elk with an obex score of 9. Note the heavy staining in the IP and OP layers, with less staining in other layers;
the absences of intracytoplasmic staining of the neurons (N) of the ganglion cell layer and the lack of accumulation of small aggregates of
chromogen on the inner surface of the OLM in both elk; and the granular staining in the layer of photoreceptor cells (PRC).
Immunohistochemical staining: Anti Prion (99), monoclonal antibody 99, streptavidin–alkaline–phosphatase method. Hematoxylin/bluing
counterstain. 132MM: codon 132, elk identified as homozygous for the wild-type allele encoding methionine. CWD, chronic wasting disease.
Figure 6. Photomicrograph of the retina of a CWD-positive 132ML Rocky Mountain elk with an obex score of 10 (A) and a 132LL elk with an
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linear and granular patterns were found in these elk, but the lin-
ear pattern was more prominent. Spongiform degeneration was
confined to the obex and not found in nuclei of the visual path-
way. PrPCWD immunoreactivity or histological lesions were not
detected in any layer of retina in these 2 elk.
Obex score ¼ 7. Three elk (132MM) had an obex score of 7.
PrPCWD immunoreactivity was detected in the optic tracts of 1
elk; in the retina, lateral geniculate nucleus, and optic radia-
tions of 2; and in the visual cortex, oculomotor nucleus, and
superior colliculus of all 3. The patterns of PrPCWD immunor-
eactivity were predominately granular, but areas of linear stain-
ing were still found. An increased number of plaques of
PrPCWD immunoreactivity were found in all visual pathways
in the brain. In most areas, these plaques appeared to be sur-
rounding and filling the cytoplasm of astrocytes. Mild spongi-
form degeneration was found within ocular motor nucleus and
superior colliculus. PrPCWD immunoreactivity was detected in
the inner plexiform layer of the retina in one (Fig. 5A) and in
the inner and outer plexiform layer in the other. The pattern
of PrPCWD immunoreactivity in the retina of the 132MM elk
was characterized by light red granular chromogen staining that
was first detected in the inner plexiform layer.
Obex score ¼ 8. Five elk (three 132MM, one 132ML, and
one 132LL) had an obex score of 8. PrPCWD immunoreactivity
was detected in the retina of two 132MM elk and the 132ML
and 132LL elk. PrPCWD immunoreactivity was detected in the
optic nerve, optic chiasm, and optic tracts in two 132MM elk.
PrPCWD immunoreactivity was detected in the lateral genicu-
late nucleus, optic radiations, visual cortex, oculomotor
nucleus, and superior colliculus in all 5 elk. The pattern of
immunoreactivity in these elk was of the coarse granular pat-
tern with an increased number of plaques. Linear staining was
minimal. Mild to moderate spongiform degeneration was found
in the nuclei of the visual pathways within the brain. PrPCWD
immunoreactivity was detected in multiple layers of the
retina in all 5 elk. All layers had some degree of PrPCWD
immunoreactivity, except the outer limiting membrane and the
pigmented epithelium. Layers of the retina with the most intense
PrPCWD immunoreactivity were the inner and outer plexiform
layers. Intracytoplasmic PrPCWD immunoreactivity within neu-
rons of the ganglion cell layer was present in the 132ML elk
but was a prominent feature in the 132LL elk (Fig. 6A, 6B).
Intracytoplasmic PrPCWD immunoreactivity within neurons of
the ganglion cell layer was not present in the 132MM elk.
Small aggregates of PrPCWD immunoreactivity were present
on the inner surface of the outer limiting membrane in
132LL elk but not in 132MM or 132ML elk.
Obex score ¼ 9–10. Four (three 132MM and one 132LL) elk
had an obex score of 9, and 6 had an obex score of 10 (five
132MM and one 132ML). PrPCWD immunoreactivity was
found in all the neuroanatomical visual pathways in the brain
(Figs. 3B, 4B). The patterns of PrPCWD immunoreactivity were
similar to those described in elk with an obex score of 8. Linear
staining was rare. Mild to severe spongiform degeneration was
found in the nuclei of the visual pathways in all these elk.
PrPCWD immunoreactivity was found in all layers of the retina
except the outer limiting membrane and the pigmented epithe-
lial layers in the 132MM elk. Small aggregates of PrPCWD
immunoreactivity were present on the inner surface of the outer
limiting membrane in 132LL elk but not in the 132MM elk
(Fig. 5B). A few ganglia of the retina showed evidence of cen-
tral chromatolysis, vacuolation, and necrosis (Fig. 7A, 7B) but
with slightly more frequency in the elk with a score of 10. The
overall degree of spongiform degeneration of the retina was
minimal in all genotypes.
Epitope Mapping With Amino Terminal Antibody P4 and
Carboxyl Terminal Antibody 99
The intensity and location of PrPCWD immunoreactivity
observed with mAbP4 in the brain and retinal sections were
similar to those of the brain and retinal sections in the
132MM and 132ML elk stained with mAb99. Immunoreactiv-
ity with mAbP4 was identical in character and pattern to that
observed with mAb99 except in one location in the 132LL elk.
The accumulation of red chromogen granules on the inner sur-
face of the outer limiting membrane as seen in the 132LL elk
immunostained with mAb99 was not observed with mAbP4.
Lack of PrPCWD Immunoreactivity in Other Structures in
the Eye
PrPCWD immunoreactivity or histological lesions were not
found in the lens, ciliary body, iris, cornea, or sclera in any
of the 3 genotypes of the 27 CWD-positive elk.
Figure 6. (continued). obex score of 9 (B). Both elk were showing clinical signs when euthanized. Note the reduced amount of red
chromogen deposition of PrPCWD in the inner plexiform (IP) and outer plexiform (OP) layers of the retina as compared to that of the 132MM
elk. Note also the heavy intracytoplasmic staining of the neurons (N) of the ganglion cell layer and the accumulation of small aggregates of
chromogen on the inner surface of the outer limiting membrane (OLM) in the 132LL elk as compared to the 132 ML elk. Immunohistochemical
staining: Anti Prion (99), monoclonal antibody 99, streptavidin–alkaline–phosphatase method. Hematoxylin/bluing counterstain. 132MM: codon
132, elk identified as homozygous for the wild-type allele encoding methionine; 132LL: codon 132, elk identified as homozygous for the
alternative allele encoding leucine; 132ML: codon 132, elk identified as heterozygous for the wild-type allele encoding methionine and for the
alternative allele encoding leucine. CWD, chronic wasting disease; PrPCWD, prion protein associated with chronic wasting disease. Figure 7.
Photomicrograph of the retina from a CWD-positive 132ML Rocky Mountain elk with an obex score of 10. A, early lesions characterized by
central chromolysis of neurons (N) of the ganglia cell layer. B, retina of the same elk. Note unaffected (N), vacuolated (V), and dead neurons
(DN) within the ganglia cell layer. HE. 132ML: codon 132, elk identified as heterozygous for the wild-type allele encoding methionine and for
the alternative allele encoding leucine. CWD, chronic wasting disease.
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Discussion
The degree of PrPCWD immunoreactivity and spongiform ence-
phalopathy is thought to correlate with the duration of disease.
Researchers have suggested that for mule deer and white-tailed
deer, the more detectable PrPCWD and severity of spongiform
degeneration in neural tissues, the longer the animal has been
incubating the disease6,16,35; however, this relationship has not
yet been delineated in elk. Neither the pathogenesis nor the dis-
semination of the agent through the host is well defined in
Rocky Mountain elk. In this study, we examined the presumed
progression of PrPCWD dissemination along the visual pathway.
Detection of PrPCWD immunoreactivity in the retina has been
reported in mule deer35 and white-tailed deer16 with CWD,
ovine scrapie,4,12 and bovine spongiform encephalopathy,7 but
the pathway and kinetics of prion protein accumulation are not
reported. Data from this study demonstrated that detectable
PrPCWD immunoreactivity first accumulated in the visual path-
ways of the brain, before the retina. Elk with an obex score of
< 6 had no evidence of PrPCWD immunoreactivity in the optic
nerve or retina but did have PrPCWD immunoreactivity in
neural regions of the visual pathway in the brain. The first
nuclear area where PrPCWD immunoreactivity was detected
was in the superior colliculus, followed by the visual cortex
(obex score of 2). Next PrPCWD immunoreactivity was detected
in the lateral geniculate nucleus and oculomotor nucleus (obex
scores of 3 to 6). PrPCWD immunoreactivity was first detected
in the retina in elk with an obex score of 7. At this time, PrPCWD
immunoreactivity was beginning to accumulate to detectable
levels in the axonal tracts of the visual pathway (the optic radia-
tions, optic tracts, optic chiasm, and optic nerve). Elk with an
obex score of 7 usually had PrPCWD immunoreactivity in the
optic nerve and retina but at much lower intensity as compared
to that of the more advanced elk with an obex score of 9 or 10.
Elk with an obex score of < 5 were thought to be in rela-
tively early stages of disease; elk with an obex score of 6 to
7 were thought to be in the midstage of disease; and elk with
an obex grade of > 8 were in a more advanced stage. Clinical
signs were primarily observed in elk with an obex score of
10; however, 2 elk (one with a score of 8 and the other, a score
of 9) did show mild signs, but both had pneumonia at the time
of necropsy. In addition to differences in distribution, the
immunoreactivity characteristics of PrPCWD were different as
the disease progressed. The pattern of PrPCWD immunoreactiv-
ity in the brain in early cases was mostly linear, apparently
composed of small granular particles of PrPCWD immunoreac-
tivity attached to the periphery of axons or dendrites. The pat-
tern of PrPCWD immunoreactivity in later stages of disease was
more granular, including plaque formation.
Retina had detectable PrPCWD immunoreactivity in elk with
an obex score of > 7. Prion was first detected in the inner plexi-
form layer of the retina, then the inner and outer plexiform
layers. The prion then spread throughout the remaining retinal
layers, sparing the pigmented epithelial layer. In domestic sheep
with scrapie, the inner plexiform layer appears to be affected
first; then, as the disease progresses, the outer plexiform layer
accumulates PrPSc (abnormal prion protein associated with
spongiform encephalopathy).7 Further evidence suggests that
as PrPSc accumulates, there are morphologic changes in retinal
ganglion cells, rod bipolar cells, and Mu¨ller glia that are associ-
ated with functional abnormalities.28 The spread of PrPCWD in
the retina of elk may be similar to that of sheep.
The amino acid sequence of the PRNP gene at codon 132
plays a role during the incubation period of elk developing
CWD. The 132MM genotype is the most common in free-
ranging and captive elk, and it is associated with an estimated
incubation period of approximately 2.5 years. The 132ML gen-
otype is not uncommon in captive and free-ranging elk.24 CWD
was identified in this genotype at a frequency in proportion to
its abundance in the entire sampled population in a recent
study.24 The experimental incubation period in elk of this gen-
otype was approximately 3.5 years. Finally, 132LL elk are rare
in free-ranging and captive elk (< 4%) and have an experimen-
tal incubation period of approximately 5 to 6 years or lon-
ger.8,22 The elk in this study (except for the two 132LL elk)
had been incubating the disease for an unknown period, and the
number of times these elk were naturally exposed was not
known.
There were 2 patterns of PrPCWD immunoreactivity in the
retinal layers among the 132MM, 132ML, and 132LL elk.
Intracytoplasmic accumulation of PrPCWD immunoreactivity
within neurons of the ganglion cell layer of the retina was not
found in the 132MM elk, but a few neurons with intracytoplas-
mic PrPCWD immunoreactivity were detected in the 132ML
elk. Intracytoplasmic PrPCWD immunoreactivity granules
within neurons within the ganglion cell layer were a prominent
feature in the 132LL elk. This pattern was identical with the
mAb99 and mAbP4. It also appeared that even though the over-
all severity of retinal degeneration was minimal, it was nearly
nonexistent in the 132MM elk and only sporadically observed
in the 132ML and 132LL elk. In mouse models, retinal degen-
eration was noted in mice expressing PrPc (the normal cellular
isoform of the prion protein) in astrocytic, microglial, and neu-
ronal cells in the retina but not in mice expressing PrPc solely in
neurons, thereby suggesting that microglial/astrocytic prion
protein expression may be required for scrapie-induced retinal
damage.17,18 In regard to the elk in this study with naturally
occurring CWD, data suggest that the lack of intraneuronal
PrPCWD immunoreactivity in the 132MM elk indicates minimal
neuronal PrPC expression. However, if leucine is incorporated
into the PRNP gene, then neuronal PrPC expression is increased
and, therefore, PrPCWD. Likewise, the 132LL genotype may be
associated with higher neuronal PrPC expression.
The second difference was the detection of small aggregates
of PrPCWD located on the inner surface of the outer limiting
membrane in 132LL elk but not in 132MM or 132ML elk. This
pattern was observed with mAb99 but not with mAbP4. The
outer limiting membrane (or external limiting membrane) is
not actually a membrane but a series of junctional complexes
between the photoreceptor cells and the Mu¨ller cells. The
outer limiting membrane is formed by the distal ends of the
Mu¨ller cells that attach to the photoreceptor cells by zonula
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adherens–type junctions. The filamentous material associated
with these intercellular zonula adherens junctions with light
microscopy appears to be a membrane.5,15 This PrPCWD immu-
noreactivity at the inner surface of the outer limiting membrane
suggests that this junction can impede movement of PrPCWD to
some degree in the 132LL elk but not in the 132MM and
132ML elk. This may reflect a functional difference between
the Mu¨ller cells of 132MM and 132ML elk and those of the
132LL elk.
Further epitope mapping with antibodies specific for the
amino and carboxyl termini of the processed prion protein will
be needed to demonstrate a difference in intracellular process-
ing of abnormal PrPCWD in tissues of the visual pathway in
132LL elk. We have reported a novel proteinase K cleavage
site in PrPCWD extracted from brain homogenate from 132LL
elk.23 In this study, we demonstrate the novel processing in
vivo in ganglia of the retina. The reason for these differences
was not determined, but it may relate to the mechanisms by
which the leucine plays a role in the metabolism or expression
of PrPCWD or PrPC within ganglia and Mu¨ller cells.
Data from this study suggest that the retina of elk may be
affected in the latter stages of CWD, as similar to the findings
of white-tailed deer in which PrPCWD was detected in only 4 of
63 CWD-positive white-tailed deer; all 4 white-tailed deer
were in advanced disease based on obex scoring.16
Prions in the nervous system have been found to localize in
the presynaptic junctions in the brain, thereby suggesting that
prions may have a function at the synaptic junctions in humans
suffering with sporadic and variant Creutzfeldt–Jakob dis-
ease.11,20 This may explain why the inner and outer plexiform
layers of the retina were affected first and had most of the
detectable PrPCWD immunoreactivity. In domestic sheep, PrPSc
has been reported to be heavily concentrated in the synaptic
layers of the retina (inner and outer plexiform layers).7,28
In the terminal stages of CWD, there is heavy immunoreac-
tivity in neuronal regions of the brain and retina but low immu-
noreactivity in such regions the optic nerve, optic chiasm, optic
tract, and optic radiations. This finding may be due to the lack
of synaptic junctions in these predominately large axonal
tracts; therefore, these regions would not produce as much
PrPC and, as such, not support as much PrPCWD production
or accumulation.
Literature describing clinical signs of CWD has not men-
tioned visual impairment.32,37,38 Elk in terminal stages of CWD
often appear to see movement, but if one walks slowly or does
not move quickly near an affected elk, the elk does not seem to
pay much attention (personal observations, T.R.S.). This beha-
vior has been attributed to lesions in the central nervous system
rather than in the eye. The literature does suggest that abnormal
prion alters localization of synaptic proteins.25 Contributing to
this behavior, by causing visual impairment in elk in the latter
stages of CWD, is the accumulation of PrPCWD within the
retina—especially in the inner and outer plexiform layers—
with neuronal degeneration of the neurons of the ganglia cell
layer, as well as PrPCWD accumulation and spongiform degen-
eration of the nuclei of the visual pathways within the brain.
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